UK markets closed
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
79.24 +0.24 (+0.30%) GOLD FUTURES
2,310.70 -0.30 (-0.01%) Bitcoin GBP
47,233.81 +1,613.73 (+3.54%) CMC Crypto 200
1,275.78 +5.04 (+0.40%)
Catalyst Pharmaceuticals, Inc. (CPRX)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 01:33PM EDT. Market open.
| Previous close | 15.20 |
| Open | 15.33 |
| Bid | 14.98 x 200 |
| Ask | 15.05 x 100 |
| Day's range | 14.96 - 15.47 |
| 52-week range | 11.09 - 17.77 |
| Volume | |
| Avg. volume | 1,335,014 |
| Market cap | 1.771B |
| Beta (5Y monthly) | 0.88 |
| PE ratio (TTM) | 23.82 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Collegium Pharmaceutical (COLL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Catalyst Pharmaceutical (CPRX) Reports Next Week: Wall Street Expects Earnings Growth
Catalyst (CPRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Simply Wall St.
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is largely controlled by institutional shareholders who own 65% of the company
Key Insights Given the large stake in the stock by institutions, Catalyst Pharmaceuticals' stock price might be...
© 2024 Yahoo. All rights reserved.